[CAS NO. 21668-77-9] Eprodisate
PRODUCTS SPECIFICATIONS [21668-77-9]
DESCRIPTION [21668-77-9]
Overview
| MDL | MFCD00191482 |
|---|---|
| Molecular Weight | 204.22 |
| Molecular Formula | C3H8O6S2 |
| SMILES | O=S(CCCS(=O)(O)=O)(O)=O |
Summary
Eprodisate is a new compound designed to interfere with interactions between amyloidogenic proteins and glycosaminoglycans and thereby inhibit polymerization of amyloid fibrils and deposition of the fibrils in tissues [1] . Eprodisate slow the progression of AA amyloidosis-related renal disease and has possible applicability to other types of amyloidosis [2] .
Appearance
Liquid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Pure form | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : ≥ 125 mg/mL ( 612.09 mM )
* "≥" means soluble, but saturation unknown.
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 4.8967 mL | 24.4834 mL | 48.9668 mL |
| 5 mM | 0.9793 mL | 4.8967 mL | 9.7934 mL |
| 10 mM | 0.4897 mL | 2.4483 mL | 4.8967 mL |
References
Synonyms
